Could microdoses of lithium halt progression of Alzheimer’s disease in rats?
The value of lithium therapy in the treatment Alzheimer’s disease has remained a controversy in the field as the information gathered to date has been acquired using a multitude of differential approaches, conditions, formulation, timings and doses of treatment, leading to results that are difficult to compare. In a recent study, which has been published in the Journal of Alzheimer’s Disease, a team of researchers from McGill University (Montreal, Canada) has revealed that lithium in doses up to 400-times lower than what is currently being prescribed for mood disorders is capable of halting signs of advanced Alzheimer’s pathology (e.g., amyloid...